Evidence map›Paper›PMID 28077579›Full record

ArticleThe Journal of biological chemistry2017

Neuron-enriched RNA-binding Proteins Regulate Pancreatic Beta Cell Function and Survival.

Jonàs Juan-Mateu, Tatiana H Rech, Olatz Villate, Esther Lizarraga-Mollinedo, Anna Wendt, Jean-Valery Turatsinze, Letícia A Brondani, Tarlliza R Nardelli, Tatiane C Nogueira, Jonathan L S Esguerra and 4 more

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 59 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
59citing papers in PubMed, 1 pooled it
6.7field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

59 citing papers in PubMed, 1 synthesis or guideline pooled it, 74 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Association of theInternational journal of molecular sciences · 2026
    Article
  4. Review
  5. Article
  6. Article
  7. Roles of molecular motors in insulin-secreting beta cells.Current opinion in cell biology · 2025
    Review
  8. Article
  9. Alternative Splicing Regulation in Metabolic Disorders.Obesity reviews : an official journal of the International Association for the Study of Obesity · 2025
    Review
  10. Review
  11. Human Brain Organoids: A New Model to StudyJournal of fungi (Basel, Switzerland) · 2025
    Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 3 institutions in 3 countries.

Jonàs Juan-MateuULB Center for Diabetes Research, Université Libre de Bruxelles, 1070 Brussels, Belgium. Electronic address: mjuanmat@ulb.ac.be.
Tatiana H RechULB Center for Diabetes Research, Université Libre de Bruxelles, 1070 Brussels, Belgium.
Olatz VillateULB Center for Diabetes Research, Université Libre de Bruxelles, 1070 Brussels, Belgium.
Esther Lizarraga-MollinedoULB Center for Diabetes Research, Université Libre de Bruxelles, 1070 Brussels, Belgium.
Anna WendtLund University Diabetes Center, Unit of Islets Cell Exocytosis, Department of Clinical Sciences Malmö, Lund University, SE 205 02 Malmö, Sweden.
Jean-Valery TuratsinzeULB Center for Diabetes Research, Université Libre de Bruxelles, 1070 Brussels, Belgium.
Letícia A BrondaniULB Center for Diabetes Research, Université Libre de Bruxelles, 1070 Brussels, Belgium.
Tarlliza R NardelliULB Center for Diabetes Research, Université Libre de Bruxelles, 1070 Brussels, Belgium.
Tatiane C NogueiraULB Center for Diabetes Research, Université Libre de Bruxelles, 1070 Brussels, Belgium.
Jonathan L S EsguerraLund University Diabetes Center, Unit of Islets Cell Exocytosis, Department of Clinical Sciences Malmö, Lund University, SE 205 02 Malmö, Sweden.
Maria Inês AlvelosULB Center for Diabetes Research, Université Libre de Bruxelles, 1070 Brussels, Belgium.
Piero MarchettiDepartment of Clinical and Experimental Medicine, Islet Cell Laboratory, University of Pisa, 56126 Pisa, Italy.
Lena EliassonLund University Diabetes Center, Unit of Islets Cell Exocytosis, Department of Clinical Sciences Malmö, Lund University, SE 205 02 Malmö, Sweden.
Décio L EizirikULB Center for Diabetes Research, Université Libre de Bruxelles, 1070 Brussels, Belgium; Welbio, Université Libre de Bruxelles, 808 Route de Lennik, CP618, 1070 Brussels, Belgium. Electronic address: deizirik@ulb.ac.be.
Université Libre de Bruxelles · BELund University · SEUniversity of Pisa · IT

Funding

Biomarkers Of Beta Cell Stress In Type 1 Diabetes (BetaMarker)UC4DK104166 · NIDDK · INDIANA UNIVERSITY INDIANAPOLIS · PI EIZIRIK, DECIO LAKS, EVANS-MOLINA, CARMELLA · 2014 to 2014
$2.4M
NIDDK NIH HHS UC4 DK104166
6 · The paper itself

Abstract

Pancreatic beta cell failure is the central event leading to diabetes. Beta cells share many phenotypic traits with neurons, and proper beta cell function relies on the activation of several neuron-like transcription programs. Regulation of gene expression by alternative splicing plays a pivotal role in brain, where it affects neuronal development, function, and disease. The role of alternative splicing in beta cells remains unclear, but recent data indicate that splicing alterations modulated by both inflammation and susceptibility genes for diabetes contribute to beta cell dysfunction and death. Here we used RNA sequencing to compare the expression of splicing-regulatory RNA-binding proteins in human islets, brain, and other human tissues, and we identified a cluster of splicing regulators that are expressed in both beta cells and brain. Four of them, namely Elavl4, Nova2, Rbox1, and Rbfox2, were selected for subsequent functional studies in insulin-producing rat INS-1E, human EndoC-βH1 cells, and in primary rat beta cells. Silencing of Elavl4 and Nova2 increased beta cell apoptosis, whereas silencing of Rbfox1 and Rbfox2 increased insulin content and secretion. Interestingly, Rbfox1 silencing modulates the splicing of the actin-remodeling protein gelsolin, increasing gelsolin expression and leading to faster glucose-induced actin depolymerization and increased insulin release. Taken together, these findings indicate that beta cells share common splicing regulators and programs with neurons. These splicing regulators play key roles in insulin release and beta cell survival, and their dysfunction may contribute to the loss of functional beta cell mass in diabetes.

Indexed as

Alternative SplicingAnimalsApoptosisCell LineCells, CulturedCell SurvivalELAV-Like Protein 4Gene Expression RegulationGlucoseHumansInsulinInsulin-Secreting CellsRatsRNA-Binding ProteinsRNA Splicing FactorsELAV-Like Protein 4GlucoseInsulinRNA-Binding ProteinsRNA Splicing Factorsalternative splicingapoptosisautoimmunitybeta cell (B-cell)diabetesinsulin secretion

Identifiers

PMID28077579
PMCPMC5336178
OpenAlexW2575311495

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.